Other share related enquiries

Other share related enquires including notification of change of address should be forwarded to:

Boardroom Pty Limited
GPO Box 3993, Sydney, NSW 2001, Australia
Phone: +61 2 9290 9600
Fax: +61 2 9279 0664
Email: enquiries@Boardroomlimited.com.au

Share Registry

The Memphasys Limited share registry is maintained by Boardroom Pty Limited. Boardroom’s website, www.boardroomlimited.com.au, offers shareholders the ability to confirm the details of their holdings and the option of receiving communications electronically. You will be required to enter your name, address and Shareholder Reference Number (SRN) to access details of your account.

Investor contacts

Memphasys Limited Corporate Head Office

Level 1, 34-36 Richmond Road,
Homebush West, NSW 2140
Australia

Memphasys’ Investor Relations

David Tasker, Chapter One Advisors
E: dtasker@chapteroneadvisors.com.au
M: +61 433 112 936

Memphasys Limited (ASX: MEM) is an Australian-based reproductive biotechnology company commercialising the Felix™ System, a patented bio separation technology that isolates the most viable sperm cells for human assisted reproduction.

For investor and media enquiries:
David Tasker, Chapter One Advisors
E: dtasker@chapteroneadvisors.com.au
M: +61 433 112 936

Find

Level 1, 34-36 Richmond Road,
Homebush West, NSW 2140
Australia

Call

Privacy Preference Center